Enhancing Brain Tumor Diagnosis with Explainable Deep Learning and Multi-Modal Imaging Fusion

This paper highlights the significance of 'Explainable Artificial Intelligence' (XAI) in brain tumor analysis within the context of automated neuro-oncology diagnostic tools. Due to the complexity of multi-modal MRI data and the critical need for highly reliable clinical decision-making, the accurate segmentation and classification of complex tumors—such as Glioblastoma Multiforme (GBM) remain major challenges in medical imaging. Although advanced deep learning architectures like 'Convolutional Neural Networks' and 'Vision Transformers' have achieved impressive diagnostic accuracy, their "black-box" nature limits clinical trust, interpretability, and regulatory acceptance. To address these limitations, the proposed framework combines a 'hybrid 3D U-Net architecture' with a 'Multi-Head Self-Attention' (MHSA) mechanism to perform precise semantic segmentation across T1, T1c, T2, and FLAIR MRI modalities. Furthermore, the integration of 'Explainable AI' techniques such as SHAP and Grad-CAM provides transparent and quantitative explanations for the model's predictions, thereby enhancing physician trust and improving diagnostic accountability. The framework also utilizes 'Federated Learning' and 'Generative Diffusion Models' to mitigate data scarcity and ensure compliance with healthcare privacy regulations like HIPAA and GDPR. Overall, the proposed architecture is highly suitable for next-generation AI-assisted neuro-oncology systems, as it integrates interpretability, computational efficiency, diagnostic accuracy, and privacy protection into a single framework. This study indicates the need to integrate 'explainable' and 'privacy-preserving' deep learning frameworks to develop reliable, scalable, and clinically implementable neuro-oncology diagnostic systems. Key areas for future research will include large-scale clinical validation, real-time surgical application, and the assessment of the framework's impact on patient survival outcomes, treatment planning, and diagnostic efficiency.

[1] Xu, M.; Guo, L.; Wu, H.-C. (2024). Novel Robust Automatic Brain-Tumor Detection and Segmentation Using Magnetic Resonance Imaging. In: IEEE Sensors Journal, vol. 24, no. 7, pp. 10957-10964. [2] Khan, P. et al. (2021). Machine Learning and Deep Learning Approaches for Brain Disease Diagnosis: Principles and Recent Advances. In: IEEE Access, vol. 9, pp. 37622-37655. [3] L. N. Soni, A. A. Waoo, A. Agrawal, and N. Vishwakarma, “Detecting Partial Human Faces Using a Hybrid Model with Deep Learning Techniques,” Vietnam, 2023. [4] Ali, F. et al. (2023). Improving Effectiveness of Different Deep Transfer Learning-Based Models for Detecting Brain Tumors from MR Images. In: IEEE Access, vol. 11, pp. 5432-5445. [5] Chaudhari, S.; Gautam, C.S.; Waoo, A.A. (2024). Enhancing Heart Disease Prediction Accuracy: A Comparative Study of Machine Learning Models with Ensemble Method. vol. 10, no. 3, pp. 4827-4833. [6] Preetha, R.; Priyadarsini, M.J.P.; Nisha, J.S. (2024). Automated Brain Tumor Detection from Magnetic Resonance Images Using Fine-Tuned EfficientNet-B4 Convolutional Neural Network. In: IEEE Access, vol. 12, pp. 112181-112195. [7] Soomro, T.A. et al. (2023). Image Segmentation for MR Brain Tumor Detection Using Machine Learning: A Review. In: IEEE Reviews in Biomedical Engineering, vol. 16, pp. 70-90. [8] Selvaraju, R.R.; Cogswell, M.; Das, A.; Vedantam, R.; Parikh, D.; Batra, D. (2017). Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization. In: IEEE International Conference on Computer Vision (ICCV 2017). [9] Soni, S.; Singh, P.; Waoo, A.A. (2025). Machine Learning Revolutionizing Brain Health. In: Brain Informatics Technology (eds A. Ahirwar, R. Bhatt, D. Dhanya and R. Choudhary). [10] Hanga, K.M.; Kovalchuk, Y.; Gaber, M.M. (2020). A Graph-Based Approach to Interpreting Recurrent Neural Networks in Process Mining. In: IEEE Access, vol. 8, pp. 172923-172938.